Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Q5GS
|
||||
| Former ID |
DNC000393
|
||||
| Drug Name |
CD154
|
||||
| Indication | Discovery agent | Investigative | [535147] | ||
| Target and Pathway | |||||
| Target(s) | Tumor necrosisfactor receptor superfamily member 5 | Target Info | Binder | [535147] | |
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| NF-kappa B signaling pathway | |||||
| Cell adhesion molecules (CAMs) | |||||
| Toll-like receptor signaling pathway | |||||
| Intestinal immune network for IgA production | |||||
| Malaria | |||||
| Toxoplasmosis | |||||
| HTLV-I infection | |||||
| Epstein-Barr virus infection | |||||
| Transcriptional misregulation in cancer | |||||
| Asthma | |||||
| Autoimmune thyroid disease | |||||
| Systemic lupus erythematosus | |||||
| Allograft rejection | |||||
| Primary immunodeficiency | |||||
| Viral myocarditis | |||||
| Pathway Interaction Database | CD40/CD40L signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.